Immunic, Inc. (IMUX) Dividend History

Immunic, Inc. (IMUX) is a clinical-stage biopharmaceutical company focused on developing oral therapies for autoimmune and inflammatory diseases. The company's pipeline includes immune-modulating treatments aimed at conditions such as multiple sclerosis, ulcerative colitis, and psoriasis. Immunic's approach leverages innovative small molecule compounds designed to target specific pathways involved in immune system regulation.

1200 Avenue Of The Americas, New York, X1, 10036
Phone: (332) 255-9818
Website: https://www.imux.com

Dividend History

Immunic, Inc. currently does not pay dividends

Company News

  • Immunic And 2 Other Stocks Under $2 Insiders Are Buying

    The Dow Jones index closed lower by over 20 points on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision. Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga's insider transactions platform. OPKO Health The Trade: OPKO Health, Inc. (NASDAQ: OPK) 10% owner Frost Gamma Investments Trust acquired a total of 500,000 shares an average price of ...

    Benzinga
    Featured Companies: OPK
  • Immunic's (IMUX) Ulcerative Colitis Study Shows Positive Data

    Immunic (IMUX) reports positive results from the maintenance phase of the phase II study evaluating its lead candidate, vidofludimus calcium, to treat patients with ulcerative colitis.

    Zacks Investment Research
    Featured Companies: CRSP KALA KOD
  • Best Penny Stocks For 2023? 3 To Watch In March

    Hot penny stocks to watch now. The post Best Penny Stocks For 2023? 3 To Watch In March appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

    PennyStocks
    Featured Companies: AI BFRG
  • Why Immunic Plummeted by 21% on Thursday

    Word of a new share issue made investors feel queasy.

    The Motley Fool
    Featured Companies: PIPR
Page data last updated 07/24/2025 22:21:28 UTC